AM7 (drug)

AM7_structure.png

AM7 is a psychedelic drug and a member of the phenethylamine class. It is structurally related to 2C-D and DOM, and is known for its psychoactive effects. AM7 was first synthesized by the chemist Alexander Shulgin and is documented in his book PiHKAL (Phenethylamines I Have Known And Loved).

Chemical Structure and Properties

AM7 is chemically known as 1-(2,5-dimethoxy-4-methylphenyl)propan-2-amine. It belongs to the class of compounds known as phenethylamines, which are characterized by a phenyl ring bound to an amino group through an ethyl chain. The presence of methoxy groups at the 2 and 5 positions, along with a methyl group at the 4 position, contributes to its unique pharmacological profile.

Pharmacology

AM7 acts primarily as a serotonin receptor agonist, particularly at the 5-HT2A receptor, which is believed to be responsible for its psychedelic effects. The drug's action on serotonin receptors leads to alterations in perception, mood, and cognition, which are characteristic of psychedelic experiences.

Effects

The effects of AM7 are similar to those of other psychedelics, such as LSD and psilocybin. Users report visual and auditory hallucinations, altered sense of time, and changes in thought patterns. The intensity and duration of these effects can vary depending on the dose and individual sensitivity.

Dosage and Administration

AM7 is typically administered orally. The effective dose range is not well established, as it is a relatively obscure compound with limited research. Users should exercise caution and start with low doses to assess individual tolerance.

Legal Status

AM7 is not a controlled substance in most jurisdictions, but its legal status can vary. It is important to check local regulations before acquiring or using this compound.

Safety and Toxicity

There is limited information on the safety and toxicity of AM7. As with other psychedelics, there is a potential for psychological distress, particularly in individuals with a history of mental health issues. Users should be aware of the risks and take appropriate precautions.

History and Research

AM7 was first synthesized by Alexander Shulgin, a renowned chemist known for his work with psychedelic compounds. It is included in his book PiHKAL, where he describes its synthesis and effects. Despite its inclusion in PiHKAL, AM7 has not been widely studied, and there is little scientific literature on its pharmacology or toxicology.

Also see

• 2C-D
• DOM
• PiHKAL
• Phenethylamine
• Serotonin receptor